AAAAAA

   
Results: 1-12 |
Results: 12
Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer
Authors: Namer, M Soler-Michel, P Turpin, F Chinet-Charrot, P de Gislain, C Pouillart, P Delozier, T Luporsi, E Etienne, PL Schraub, S Eymard, JC Serin, D Ganem, G Calais, G Maillart, P Colin, P Trillet-Lenoir, V Prevost, G Tigaud, D Clavere, P Marti, P Romieu, C Wendling, JL
Citation: M. Namer et al., Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer, EUR J CANC, 37(9), 2001, pp. 1132-1140
Systematic esophageal endoscopy screening in patients previously treated for head and neck squamous-cell carcinoma
Authors: Petit, T Georges, C Jung, GM Borel, C Bronner, G Flesch, H Massard, G Velten, M Haegele, P Schraub, S
Citation: T. Petit et al., Systematic esophageal endoscopy screening in patients previously treated for head and neck squamous-cell carcinoma, ANN ONCOL, 12(5), 2001, pp. 643-646
A comprehensive assessment of satisfaction with care: preliminary psychometric analysis in French, Polish, Swedish and Italian oncology patients
Authors: Bredart, A Razavi, D Robertson, C Batel-Copel, L Larsson, G Lichosik, D Meyza, J Schraub, S von Essen, L de Haes, JCJM
Citation: A. Bredart et al., A comprehensive assessment of satisfaction with care: preliminary psychometric analysis in French, Polish, Swedish and Italian oncology patients, PAT EDUC C, 43(3), 2001, pp. 243-252
Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of French adjuvant study group 05 randomized trial
Authors: Adenis, A Bonneterre, J Bonneterre, ME Pion, JM Vanlemmens, L Gladieff, L de Lafontan, B Martel, P Mihura, J Roche, H Gedouin, D Kerbrat, P Lesimple, T Bremond, A Devaux, Y Delecroix, V Fumoleau, P Maugard-Louboutin, C Namer, M Goudier, MJ Morice, F Montcuquet, P Schraub, S Coudert, B Fargeot, P de Gislain, C Mayer, F Bastit, P Chevallier, B Grandgirard, A Monnier, A Sun, X Clavere, P Ollivier, JP Rhein, B Roullet, B Datchary, J Audhuy, B Barats, JC Kohser, F Dides, S Ramos, R Cattan, A Eymard, JC Pourny, C Weber, B de Laroche, G Pichon, A Seffert, P Hayat, M Zambon, E Chollet, P Van Praagh, I
Citation: A. Adenis et al., Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of French adjuvant study group 05 randomized trial, J CL ONCOL, 19(3), 2001, pp. 602-611
Alternative medicine use worldwide - The International Union Against Cancer Survey
Authors: Cassileth, BR Schraub, S Robinson, E Vickers, A
Citation: Br. Cassileth et al., Alternative medicine use worldwide - The International Union Against Cancer Survey, CANCER, 91(7), 2001, pp. 1390-1393
Unproven methods in cancer: a worldwide problem
Authors: Schraub, S
Citation: S. Schraub, Unproven methods in cancer: a worldwide problem, SUPP CARE C, 8(1), 2000, pp. 10-15
Quality of life assessment in cancerology
Authors: Schraub, S Mercier, M Arveux, P
Citation: S. Schraub et al., Quality of life assessment in cancerology, PRESSE MED, 29(6), 2000, pp. 310-318
Epirubicin-based chemotherapy in metastatic breast cancer patients: Role of dose-intensity and duration of treatment
Authors: Bastit, P Chevallier, B Chevreau, C Mihura, J Roche, H Namer, M Gedouin, D Kerbrat, P Lesimple, T Coudert, B Fargeot, P de Gislain, C Mayer, F Luporsi, E Rios, M Weber, B Bremond, A Devaux, Y Monteuquet, P Schraub, S Hayat, M Zambon, E Grandgirard, A Monnier, A Sun, X Clavere, P Ollivier, JP Rhein, B Roullet, B Chollet, P Van Praagh, I Cattan, A Eymard, JC Pourny, C Facchini, T Walter, S Dides, S Ramos, R Guiochet, N Seffert, P Perpoint, X Sztermer, JF Cretin, J Goudier, MJ Morice, F Delecroix, V Fumoleau, P
Citation: P. Bastit et al., Epirubicin-based chemotherapy in metastatic breast cancer patients: Role of dose-intensity and duration of treatment, J CL ONCOL, 18(17), 2000, pp. 3115-3124
Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study
Authors: Horiot, JC Lipinski, F Schraub, S Maulard-Durdux, C Bensadoun, RJ Ardiet, JM Bolla, M Coscas, Y Baillet, F Coche-Dequeant, B Urbajtel, M Montbarbon, X Bourdin, S Wibault, P Alfonsi, M Calais, G Desprez, P Pene, F Lapeyre, M Vinke, J Maral, J
Citation: Jc. Horiot et al., Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study, RADIOTH ONC, 55(3), 2000, pp. 233-239
Quality of life in oncology
Authors: Schraub, S Mercier, M
Citation: S. Schraub et M. Mercier, Quality of life in oncology, B CANCER, 87(1), 2000, pp. 117-120
Imaging and oncology: necessarily associated
Authors: Schraub, S Dopff-Kaissling, A
Citation: S. Schraub et A. Dopff-kaissling, Imaging and oncology: necessarily associated, J RADIOLOG, 80(12), 1999, pp. 1619-1620
Assessment of the impact of improved local control by radiotherapy on survival in cancer patients
Authors: Bartelink, H Van Der Schueren, E Budach, V Bernier, J Horwich, A Jancar, B Roth, S Landmann, C Jassem, J Khoury, G Storme, G Cosset, JM Batterman, J Van Den Weijngaert, D Hamers, HP Renaud, A Van Houtte, P Cionini, L Horiot, JC Schraub, S Nguyen, TD Eschwege, F Bolla, M Sylvestre, ME Gerard, JP de Vilhena, M Levendag, PC Leer, JW Sola, AB Mirimanoff, RO Pourquier, H Bey, P Le Fur, R Calitchi, E Lefloch, O Monpetit, E Gonzalez, D Kurtz, JM Meerwaldt, JH Johansson, KA Van Daal, W Jager, JJ Muller, RP
Citation: H. Bartelink et al., Assessment of the impact of improved local control by radiotherapy on survival in cancer patients, BIOM HLTH R, 24, 1998, pp. 370-374
Risultati: 1-12 |